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A simple, rapid, accurate and sensitive method was developed for quantitative analysis of dexamethasone 
acetate in microemulsions using high performance liquid chromatography (HPLC) with UV detection. The 
chromatography parameters were stainless steel Lichrospher 100 RP-18 column (250 mm x 4 mm i.d., 5 
µm particle size), at 30 ± 2 ºC. The isocratic mobile phase was methanol:water (65:35; v/v) at a flow rate 
of at 1.0 mL.min-1. The determinations were performed using UV-Vis detector set at 239 nm. Samples were 
prepared with methanol and the volume injected was 20 µL. The analytical curve was linear (r2 0.9995) 
over a wide concentration range (2.0-30.0 µg.mL-1). The presence of components of the microemulsion 
did not interfere in the results of the analysis. The method showed adequate precision, with a relative 
standard deviation (RSD) smaller than 3%. The accuracy was analyzed by adding a standard drug and 
good recovery values were obtained for all drug concentrations used. The HPLC method developed in 
this study showed specificity and selectivity with linearity in the working range and good precision and 
accuracy, making it very suitable for quantification of dexamethasone in microemulsions. The analytical 
procedure is reliable and offers advantages in terms of speed and low cost of reagents. 
Uniterms: Dexamethasone acetate/determination. Microemulsions/quantitative analysis. High 
performance liquid chromatography/quantitative analysis. Analytical method/validation.
Um método simples, rápido, preciso e sensível foi desenvolvido para a análise quantitativa de acetato de 
dexametasona em microemulsões usando cromatografia líquida de alta eficiência (CLAE). Os parâmetros 
cromatográficos foram: coluna cromatográfica Lichrospher 100 RP-18, (250 mm x 4 mm i.d., 5 µm 
partícula tamanho), com temperatura de coluna de 30 ± 2 ºC. A fase móvel foi composta de metanol: 
água (65:35; v/v) com fluxo isocrático de 1 mL.min-1 e volume de injeção de 20 µL. As determinações 
foram realizadas utilizando detector UV-Vis no comprimento de onda de 239 nm. A curva analítica 
mostrou-se linear (r2 0,999) em uma ampla faixa de concentração (2,0-30,0 µg.mL-1). A presença de 
componentes da microemulsão não interferiu nos resultados da análise. O método mostrou precisão 
adequada, com desvio padrão relativo menor que 3%. A exatidão foi analisada pela adição de padrões 
do fármaco e valores de recuperação dentro dos limites recomendáveis foram obtidos para todas as 
concentrações estudadas. O método por CLAE mostrou especificidade e seletividade com linearidade 
dentro da faixa de concentração utilizada e precisão e exatidão que tornam o método adequado para a 
análise de dexametasona em microemulsões. O procedimento analítico é fidedigno e oferece vantagens 
em termos de velocidade e custo de reativos.
Unitermos: Acetato de dexametasona/determinação. Microemulsões/análise quantitativa. Cromatografia 
líquida de alta eficiência/análise quantitativa. Método de análise/validação.
INTRODUCTION
Since 1948, with the introduction of cortisone and 
later hydrocortisone (1951), anti-inflammatory steroids 
have become a prominent pharmacological class. They 
are currently the drugs of choice for the treatment of se-
veral diseases, despite their adverse side effects (Avery, 
Woolfrey, 1997). 
The use of topical steroid preparations represented 
a major advance in dermatology. Dexamethasone ace-
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tate (9-fluoro-11 ß-17,21-trioxy-16α-methylpregna-1,4-
diene-3,20-dione 21-acetate monohydrate) is a steroid 
indicated for the treatment of several pathologies due to 
its anti-inflammatory and inmunosuppresor effects (Figure 
1). This steroid is frequently incorporated in ointments, 
creams, lotions, aerosols and microemulsions (Gasco et 
al., 1988; Hashigushi et al., 1997; Vianna et al., 1998; 
Lehmann et al., 2001). 
Microemulsions are isotropic and thermodynami-
cally stable solutions, generally composed of a combina-
tion of three to five components: oil, water, surfactant, co-
surfactant and active substance (Constantinides, Scalart, 
1997). The microemulsions show great potential as drug 
delivery systems because they can improve the solubility, 
absorption and therapeutic efficacy of the drug (Formariz 
et al., 2005).
Surfactants are extensively used to stabilize drug 
delivery systems. Commonly they are molecules self-
assembled in water or in oil, leading to the formation of 
a well defined microstructure. Even a single surfactant 
can display a rich variety of structures that depends on 
several parameters, such as water content and tempera-
ture. Nevertheless, these microheterogeneous systems 
can interfere with drug separation and detection, and an 
adequate analytical method is needed to analyze the drug 
carried by these systems. 
Capillary electrophoresis has been used to determine 
of dexamethasone (Guo et al., 2004) in pharmaceutical 
dosage forms. Thin-layer chromatographic-densitometric 
method is also described for the analysis of dexamethasone 
in an ointment (Krzek et al., 2005). Another method for 
analysis of dexamethasone acetate in ointments reported 
is flow-injection chemiluminescence (Wu, Lv, 2007). Al-
though these methods are versatile tools in pharmaceutical 
analysis, they are time-consuming. HPLC remains the 
analytical method of choice, especially for analysis for 
topical formulations, owing to their complex composi-
tion. Few HPLC methods are described on the literature 
for the analysis of dexamethasone acetate in creams and 
ointments (Capella-Peiró, 2002, Garcia et al., 2003) and in 
other pharmaceutical forms (Vianna et al., 1998; Milojevic 
et al., 2002). HPLC is very useful for analysis of complex 
samples, such as ointments and creams, as it provides drug 
separation, determination and the elimination of most 
interference problems (Willians et al., 1981). However, 
no HPLC method for the analysis of the dexamethasone 
in microemulsion has been described.
The validation of an analytical method must demons-
trate that it fulfills all the requirements of the analytical 
applications, ensuring the reliability of the results. For this 
reason, the tests must show that its specificity, linearity, 
precision, sensitivity, accuracy and limit of quantification 
are adequate for the analysis (ICH, 2003; British Pharma-
copoeia, 2001; ANVISA, 2003; USP, 2004).
The aim of this study was to develop a simple, ra-
pid, specific, precise and accurate reversed-phase HPLC 
method for the determination of dexamethasone acetate 
in microemulsions. The parameters used to validate the 




Dexamethasone acetate (Purifarma, São Paulo, 
Brazil) (99%) was used without further purification. The 
microemulsion was composed of isopropyl myristate 
(Henrifarma, São Paulo, Brazil) as the oily phase, PPG-5 
Ceteth-20 (Croda, São Paulo, Brazil) as surfactant and 
distilled water. 
The drug-containing microemulsions and the solu-
tions were stable throughout the experiments and remained 
stable for a further six months.
Methanol (HPLC grade - Mallinckrodt, USA) was 
used to prepare the mobile phase and to dilute the samples. 
Water was obtained by distillation.
Methods
Instrumentation and chromatographic conditions
The method was performed on a Shimadzu Sys-
tem consisting of: Solvent Delivery Module LC-9A, 
Ultraviolet-Visible Spectrophotometric Detector Module 
SPD-6AV, Column Oven Module CTO-6A and System 
Controller Module SCL-6B with a Rheodyne injection 
valve with a 20 µL loop attached.
Isocratic Chromatographic separations were carried 
out in a stainless steel Merck Lichrospher 100 RP-18 colu-
FIGURE 1 - Chemical structure of dexamethasone acetate.
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mn (250 mm x 4 mm i.d., 5 µm particle size) at 30 ºC, with 
a methanol-water (65:35 v/v) mobile phase and flow-rate 
of 1.0 mL.min-1. The mobile phase was filtered through 
a 0.45 µm Millipore membrane filter and degassed with 
helium for 15 min before use. The determinations were 
performed with UV-Vis detector set at 239 nm. The sensi-
tivity was 0.08 AUFS and the chart speed 2.5 mm.min-1.
Dexamethasone acetate standard – analytical curve
The methanolic dexamethasone acetate standard so-
lution (1mg.mL-1) was freshly prepared by transferring 10 
mg of dexamethasone acetate standard, accurately weighed, 
to a 10 mL volumetric flask, using methanol to transfer the 
sample and to complete the volume. A 2.5 mL aliquot of 
this primary solution was volumetrically transferred to a 
25 mL volumetric flask and methanol added to make up 
the volume, giving a 100 µg.mL-1 stock solution. Working 
solutions, in a concentration range of 2.0 - 30.0 µg.mL-1, 
were prepared by diluting the stock solution in methanol. 
To obtain the analytical curve, 20 µL of each concentration 
was injected into the HPLC system and the area under cur-
ve (AUC) for each peak was plotted versus dexamethasone 
concentration. The analyses were carried out in triplicate 
and a straight line standard curve was obtained by linear 
regression of the experimental data.
Microemulsion preparation
All components, isopropyl myristate, PPG-5 Ce-
teth-20 and distilled water, were accurately weighed and 
heated to temperatures between 50 and 60 ºC, with mag-
netic stirring to ensure complete mixing. 
Incorporation of dexamethasone acetate into 
microemulsions
Drug-loaded microemulsions were prepared by 
adding 0.1% (w/w) dexamethasone acetate to the micro-
emulsion at room temperature. The mixture was gently 
shaken to ensure complete mixing and solubilization. 
The drug-containing microemulsion and solutions were 
shielded from light by storing in flasks wrapped with 
aluminum foil.
HPLC assay of dexamethasone acetate in 
microemulsions 
For this assay, 1 g of microemulsion containing 0.1% 
(w/w) dexamethasone acetate was accurately weighed 
and dissolved in methanol, giving a solution of nominal 
concentration 15 µg.mL-1. After that, the solution was 
filtered through a 0.22 µm Millipore membrane filter and 
analyzed by HPLC. All determinations were conducted 
in triplicate.
Method Validation 
The method was validated in accordance with Inter-
national Conference on Harmonization guidelines (ICH-
2003) for validation of analytical procedures. 
Specificity and Selectivity
These parameters were determined by comparing the 
chromatograms of the dexamethasone acetate standard, 
drug-loaded microemulsion and microemulsion without 
drug.
Linearity
The linearity was determined from the triplicate 
analytical curves obtained by HPLC analysis of dexame-
thasone acetate standard solutions. 
Accuracy
The accuracy was determined by the standard addi-
tion method. Amounts of 5.0; 10.0; 15.0 µg.mL of the 
dexamethasone acetate standard were added to the micro-
emulsions samples in which 10.0 µg.mL-1 of the drug had 
been incorporated previously. The final concentrations of 
the fortified solutions were 15.0, 20.0 and 25.0 µg.mL-1 of 
dexamethasone. The recovery experiments were perfor-
med in triplicate for each concentration. 
Precision
The precision of the assay was determined by repea-
tability (intra-day) and intermediate precision (inter-day). 
The intra-day precision was calculated as the relative 
standard deviation (RSD) of results from ten standard 
samples, during the same day, and the inter-day precision 
was studied by comparing the assays on two different 
days. Ten sample solutions (15.0 µg.mL-1) were prepared 
and assayed, and the standard deviation (SD) and RSD 
were calculated.
Limit of quantification 
The lower limit of quantification was the smallest 
analytical concentration which could be measured with 
precision and accuracy.
RESULTS AND DISCUSSION
In this study, a HPLC method for quantitative 
analysis of dexamethasone acetate in microemulsion was 
developed and validated.
Specificity and Selectivity
The specificity and selectivity describe the capacity 
M. C. C. Urban, R. M. Mainardes, M. P. D. Gremião90
of the analytical method to measure the drug in the presence 
of impurities, excipients, degradation products or matrix 
components (ICH, 2003; Brasil, 2003; USP, 2004). These 
parameters were determined by comparing the chromato-
grams of the dexamethasone acetate standard, drug-loaded 
microemulsion and microemulsion without drug.
The chromatogram of the dexamethasone acetate 
standard presented a peak in the time retention of 6.7 (Fi-
gure 2B). The chromatogram of dexamethasone-loaded 
microemulsion sample (Figure 2C) showed a peak and 
retention time similar to dexamethasone acetate standard 
(Figure 2B). The components of the microemulsion do not 
interfere with the analysis, therefore no peak is observed in 
the region of the main peak of dexamethasone (Figure 2A). 
The chromatogram peaks are well resolved, indicating 
the high specificity of the method. The retention time of 
6.7 min is a good value for routine procedures in quality 
control. In fact, compared to values obtained elsewhere 
for analysis of dexamethasone acetate in creams (8.5 min 
- Garcia et al., 2003) and ointments (11.7 min - Zivanovic 
et al., 2005), the present method proved advantageous, 
with a shorter retention time.
Linearity
The analytical curve for dexamethasone acetate 
standard was constructed by plotting the area under the 
curve (AUC) of the main peak versus drug concentration. 
It was found to be linear over a wide concentration range 
(2.0-30.0 µg.mL-1) with a correlation coefficient of 0.9995. 
The straight line equation obtained from the experimental 
results was found to be (Equation 3):
y = 40456.425x + 6537.444  (3)
The data were validated by analysis of variance, 
which demonstrated significative linear regression and 
non-significative deviation from linearity (P < 0.05). The 
RSD of the slope and of the intercept of the three lines 
were 1.95 % and 2.9 %, respectively. 
Thus, this HPLC method can be considered to 
show adequate linearity in the concentration range 
(2.0-30.0 µg.mL-1) for quantitative analysis of dexa-
methasone acetate under the experimental conditions 
described.
Accuracy
Accuracy is one of the most important parameters 
of an analytical methodology and it can be expressed as 
the percent recovery of known amounts of drug added 
to a sample. The recoveries were determined by adding 
known amounts of the dexamethasone acetate reference 
substance (5.0 µg.mL-1, 10.0 µg.mL-1 and 15.0 µg.mL-1) 
to the microemulsion sample (10.0 µg.mL-1). The results 
presented in Table I refer to the average of three assays 
FIGURE 2 - HPLC chromatogram of (A) microemulsion, (B) dexamethasone acetate standard (20 μg.mL-1) and (C) dexamethasone 
acetate-loaded microemulsion (20 μg.mL-1 of drug). (Isocratic mobile phase of methanol:water (65:35 v/v) flow rate at 1 mL.min-1, 
Lichrospher 100 RP-18 column at 30±2 ºC, UV detector at 239 nm)
TABLE I - Analytical recovery of dexamethasone standard 











112 ± 1.3 
112 ± 6.1 
114 ± 6.5 
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for each concentration. The results are in good agreement 
with acceptable values for the validation of an analytical 
procedure (recovery = 80-120 %) (Brittain, 1998; ANVI-
SA, 2003).
Precision
The precision refers to the variability of the results 
in repeated analyses of the sample under identical expe-
rimental conditions. The method was validated by eva-
luating the intra- and inter-day precision. The precision 
was calculated from an average of ten determinations 
of a homogeneous sample (USP, 2004). The intra- and 
inter-day precision assays were expressed as relative 
standard deviation (RSD) 0.89 and 0.43, respectively, 
indicating that the method presents a good precision 
(Brittain, 1998). The detailed precision data are shown 
at Table II.
Limit of quantification
The lower limit of quantification was determined 
to be 2 µg.mL-1, with a relative standard deviation lower 
than 10%.
CONCLUSION
The results show that the HPLC method presented 
here can be considered suitable for the analytical deter-
mination of dexamethasone acetate in microemulsions, 
owing to its high selectivity and specificity, linearity in the 
concentration range used and high precision and adequate 
accuracy at the concentrations studied.
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